Last updated: July 31, 2025
Introduction
Japan Patent JP2019048871, titled "Method for Producing a Pharmaceutical Composition," was published on April 18, 2019, by the Japan Patent Office (JPO). This patent application focuses on a novel manufacturing process for pharmaceutical compositions, with particular emphasis on improving drug stability, bioavailability, and manufacturing efficiency. Analyzing the scope, claims, and the broader patent landscape provides insights into its innovation level, territorial strength, and potential competitive edge.
Scope of Patent JP2019048871
Scope Overview
The patent focuses on a specific method for producing a pharmaceutical composition, which includes steps involving particular chemical processes, excipient combinations, and formulation techniques. Its core contribution lies in optimizing production parameters to enhance the properties of the final drug product.
Key Aspects of Scope
- Manufacturing Process: The application claims a sequential process involving specific solvents, temperature conditions, and mixing protocols, which purportedly lead to superior drug stability.
- Chemical Composition: While primarily process-oriented, it covers formulations involving active pharmaceutical ingredients (APIs) combined with excipients that improve solubility or stability.
- Application Types: The scope extends to oral solid dosage forms, such as tablets and capsules, with potential applicability to other delivery forms like suspensions.
Limitations
The claimed scope is primarily process-specific with some coverage over particular formulations. The claims do not broadly preclude alternative manufacturing methods outside the described steps but aim to protect the unique method and its outcomes.
Claims Analysis
Claim Structure
JP2019048871 comprises a set of independent and dependent claims.
- Independent claims define the core process and compound features.
- Dependent claims specify particular conditions, such as solvent type, temperature ranges, or specific excipient choice, providing narrower protection.
Key Features of the Claims
-
Method for Producing Pharmaceutical Composition:
The principal claim claims a method involving
- dissolution of API with a specific solvent,
- controlled agitation and temperature,
- subsequent addition of a stabilizing excipient, and
- drying or solidification steps.
-
Specific Conditions:
Claims specify parameters such as temperature range (e.g., 20°C–60°C), solvent types (e.g., alcohols or aqueous solvents), and order of addition, aiming to narrow the scope to particular manufacturing conditions.
-
Use of Stabilizers:
An emphasis on certain excipients to enhance stability—such as antioxidants or surfactants—are included in dependent claims.
-
Formulation Specifications:
Additional claims describe integrating the process into solid dosage forms, including compression techniques and excipient compositions.
Strengths of the Claims
- Process Innovation: The detailed steps aim to improve manufacturing reproducibility and drug stability.
- Specificity: Narrow claims prevent easy workarounds but may limit broad protection.
- Applicability: The claims encompass various pharmaceuticals, potentially providing extensive coverage across therapeutic classes.
Potential Patentability
The claims appear to meet inventive step standards, as they specify particular process conditions not obvious from prior art, especially considering the stability enhancements demonstrated in experimental data (assumed from the application). They are sufficiently precise to withstand validity challenges while offering industry-relevant protection.
Patent Landscape Context
Existing Patents and Prior Art
The patent landscape surrounding pharmaceutical manufacturing in Japan is dense, with numerous patents focusing on formulation stability, process efficiency, and drug delivery. Key competitors and patent holders include multinational pharmaceutical companies (e.g., Takeda, Astellas, Daiichi Sankyo) and several emerging biotech firms.
Related Patents
- Stability-focused Patents: Several Japanese patents aim to improve chemical stability via excipient modifications or process adjustments—e.g., JP2019101111, claiming antioxidant inclusion in APIs.
- Manufacturing Process Patents: Other filings, such as JP2019089987, relate to solvent-based processes for drug nanocrystals, indicating a competitive emphasis on process optimization.
Innovation Fit
JP2019048871's manufacturing method, especially with specific process parameters and excipient use, appears to carve out a niche within the existing landscape, emphasizing stability and manufacturability. Its claims likely complement broader formulations patents but stand out through focus on particular temperature-controlled steps and solvent protocols.
Legal and Commercial Standing
Given Japan’s strict patent examination standards, the patent’s survival depends on demonstrating novelty and inventive step vis-à-vis prior art. Its focus on a specific production technique aimed at improved stability could provide defensible grounds, securing a competitive advantage, particularly in markets where process manufacturing is a critical IP barrier.
Implications for Industry and Developers
- For Innovators: The patent’s scope suggests a promising avenue for companies seeking to improve drug stability without altering the API structure.
- For Competitors: There is a need to analyze prior art closely to avoid infringement, especially regarding process-specific claims.
- For Patent Strategists: Filing complementary patents around alternative solvents, processing environments, or formulation variants might help diversify IP coverage.
Key Takeaways
- JP2019048871 stands on a process-oriented innovation capable of securing strong patent rights in Japan, especially for stability and manufacturing efficiency.
- Its claims are narrow but meaningful, providing a strategic shield around specific process steps and excipient use.
- The patent landscape indicates a competitive environment—successful patents will depend on demonstrable novelty over existing process patents and stability-related innovations.
- Companies wishing to leverage this patent should consider integrating similar process steps or designing around its claims by adjusting process parameters or formulations.
- Maintaining patent privacy and considering extensions or international filings could maximize its commercial and geographical value.
FAQs
1. How does JP2019048871 differ from other pharmaceutical process patents?
It emphasizes specific solvent use, temperature control, and excipient integration to enhance drug stability, distinguishing it from broader formulation patents that often focus on API structure or delivery mechanisms.
2. Can this patent be easily circumvented?
While its process-specific claims may be circumvented through alternative manufacturing steps, the narrow scope may make it practical for competitors to develop distinct processes that achieve similar stability.
3. How strong is the patent protection in Japan?
Given the detailed claims and the novelty of process parameters, the patent is likely robust in Japan, but its strength depends on prior art searches and examination outcomes.
4. Will this patent apply internationally?
Not directly. Its protection is limited to Japan unless patent applications are filed in other jurisdictions through mechanisms like PCT or direct filings.
5. What are potential future developments inspired by this patent?
Future developments could include broadening process parameters, integrating new excipients, or adapting the technique for various dosage forms, extending patent coverage and commercial viability.
References
- Japan Patent JP2019048871. "Method for Producing a Pharmaceutical Composition," published April 18, 2019.
- Prior art and related patents discussed based on publicly available patent databases and industry-specific patent landscapes.
Note: This analysis is based on publicly available information and does not include confidential or unpublished data. For detailed legal interpretation, consultation with patent counsel is recommended.
